tradingkey.logo
tradingkey.logo
Search

Zentalis Pharmaceuticals Inc

ZNTL
Add to Watchlist
4.740USD
-0.180-3.66%
Close 07-31 16:00ETQuotes delayed by 15 min
337.42MMarket Cap
LossP/E TTM

ZNTL Cash Flow Statement

You can access the annual and quarterly cash flow statements of Zentalis Pharmaceuticals Inc to evaluate its financial soundness and stability.
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2026Q1
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q3
FY2021Q2
FY2021Q1
FY2020Q4
FY2020Q3
FY2020Q2
FY2020Q1
FY2019Q1
Operating cash flows (indirect method)
Cash flow from continuing operating activities
-0.98%-32.96M
22.07%-30.94M
38.78%-26.96M
1.23%-34.71M
37.21%-32.64M
2.21%-39.70M
-13.91%-44.05M
55.67%-35.14M
-5.46%-51.97M
-8.76%-40.60M
-16.46%-38.66M
-84.24%-79.28M
1.82%-49.28M
-0.83%-37.33M
0.87%-33.20M
6.69%-43.03M
-33.97%-50.20M
-35.33%-37.02M
-62.86%-33.49M
-109.29%-46.11M
-122.09%-37.47M
---27.36M
---20.56M
---22.03M
-87.33%-16.87M
---9.01M
Net income from continuing operations
26.78%-35.35M
25.82%-35.22M
33.54%-26.69M
69.56%-26.87M
-580.87%-48.28M
22.10%-47.47M
27.70%-40.16M
21.58%-88.28M
115.87%10.04M
-10.83%-60.94M
-1.91%-55.54M
-64.59%-112.56M
-6.79%-63.26M
-9.76%-54.98M
-419.44%-54.50M
-24.21%-68.39M
-17.43%-59.24M
-24.13%-50.09M
69.73%-10.49M
-101.75%-55.06M
-210.71%-50.44M
---40.36M
---34.66M
---27.29M
-87.41%-16.23M
---8.66M
Operating gains losses
-89.32%151.00K
-22.50%3.14M
-50.16%160.00K
135.96%160.00K
29.01%1.41M
1102.67%4.05M
-7.76%321.00K
-229.36%-445.00K
-79.37%1.10M
-6.13%337.00K
-7.20%348.00K
-1.15%344.00K
1444.48%5.31M
71.77%359.00K
173.72%375.00K
192.44%348.00K
335.44%344.00K
533.33%209.00K
168.63%137.00K
213.16%119.00K
107.89%79.00K
--33.00K
--51.00K
--38.00K
80.95%38.00K
--21.00K
Deferred tax
----
----
----
----
----
--0.00
--0.00
100.00%0.00
100.00%0.00
100.00%0.00
--0.00
---756.00K
---97.00K
---769.00K
----
----
----
-100.00%0.00
----
----
----
--17.00K
----
----
----
----
Other non-cash items
-103.74%-224.00K
97.90%-431.00K
92.93%-517.00K
-102.92%-781.00K
110.05%5.99M
-351.59%-20.57M
-245.07%-7.31M
126.00%26.72M
-1726.80%-59.57M
-83.97%-4.55M
-67.38%-2.12M
9265.12%11.82M
-2333.56%-3.26M
-1363.27%-2.48M
-762.83%-1.27M
-155.60%-129.00K
-49.48%146.00K
-40.96%196.00K
20.13%191.00K
256.92%232.00K
--289.00K
--332.00K
--159.00K
--65.00K
----
----
Change in working capital
-141.51%-728.00K
80.53%-1.38M
83.88%-1.17M
-159.07%-8.33M
110.76%1.75M
-168.91%-7.08M
-251.87%-7.26M
373.02%14.10M
-305.70%-16.30M
157.80%10.27M
-50.37%4.78M
-272.88%-5.16M
-20.08%-4.02M
68.27%3.98M
-23.64%9.63M
326.12%2.99M
-215.37%-3.35M
-49.96%2.37M
89.85%12.61M
47.68%-1.32M
389.23%2.90M
--4.73M
--6.64M
---2.52M
-103.45%-1.00M
---493.00K
-Change in receivables
-100.00%0.00
100.00%0.00
--0.00
--0.00
--5.00M
---5.00M
----
----
----
----
----
----
----
-103.85%-4.00K
103.88%4.00K
----
-100.00%0.00
135.25%104.00K
-110.20%-103.00K
268.18%243.00K
16800.00%169.00K
---295.00K
---49.00K
--66.00K
-99.56%1.00K
--225.00K
-Change in prepaid expenses
46.76%973.00K
-406.14%-698.00K
-87.52%679.00K
46.26%2.35M
162.78%663.00K
147.60%228.00K
526.00%5.44M
259.80%1.61M
63.80%-1.06M
74.59%-479.00K
-165.72%-1.28M
59.94%-1.00M
29.78%-2.92M
-131.29%-1.89M
-65.51%1.94M
2.75%-2.51M
-206.12%-4.15M
-407.55%-815.00K
670.14%5.63M
31.13%-2.58M
-29.24%-1.36M
--265.00K
---988.00K
---3.75M
-356.52%-1.05M
---230.00K
-Change in payables and accrued expense
63.93%-1.45M
71.39%-733.00K
83.54%-1.98M
-189.72%-10.58M
73.62%-4.02M
-124.64%-2.56M
-289.79%-12.01M
368.48%11.80M
-980.72%-15.25M
105.88%10.40M
-1.94%6.33M
-195.54%-4.39M
-145.82%-1.41M
214.45%5.05M
-13.65%6.45M
200.39%4.60M
-117.36%-574.00K
-69.46%1.61M
-4.66%7.47M
32.10%1.53M
6139.62%3.31M
--5.26M
--7.84M
--1.16M
111.35%53.00K
---467.00K
Cash from non-recurring investing activities
Cash from operating activities
-0.98%-32.96M
22.07%-30.94M
38.78%-26.96M
1.23%-34.71M
37.21%-32.64M
2.21%-39.70M
-13.91%-44.05M
55.67%-35.14M
-5.46%-51.97M
-8.76%-40.60M
-16.46%-38.66M
-84.24%-79.28M
1.82%-49.28M
-0.83%-37.33M
0.87%-33.20M
6.69%-43.03M
-33.97%-50.20M
-35.33%-37.02M
-62.86%-33.49M
-109.29%-46.11M
-122.09%-37.47M
---27.36M
---20.56M
---22.03M
-87.33%-16.87M
---9.01M
Investing cash flow
Net cash from continuing investing activities
780.00%34.00K
---129.00K
--0.00
-586.21%-564.00K
-112.50%-5.00K
-100.00%0.00
-100.00%0.00
-63.64%116.00K
--40.00K
8.13%173.00K
-94.52%91.00K
14.75%319.00K
----
-92.70%160.00K
-37.62%1.66M
-66.06%278.00K
3.21%450.00K
231.47%2.19M
6390.24%2.66M
3176.00%819.00K
1306.45%436.00K
--661.00K
--41.00K
--25.00K
-24.39%31.00K
--41.00K
Capital expenditures
--34.00K
--0.00
--0.00
-100.00%0.00
-100.00%0.00
-100.00%0.00
-100.00%0.00
-43.26%181.00K
--40.00K
8.13%173.00K
-94.52%91.00K
14.75%319.00K
----
-92.70%160.00K
-37.62%1.66M
-66.06%278.00K
3.21%450.00K
231.47%2.19M
6390.24%2.66M
3176.00%819.00K
1306.45%436.00K
--661.00K
--41.00K
--25.00K
-24.39%31.00K
--41.00K
Net cash flow from disposal of fixed assets
780.00%34.00K
---129.00K
--0.00
-586.21%-564.00K
-112.50%-5.00K
-100.00%0.00
-100.00%0.00
-63.64%116.00K
--40.00K
8.13%173.00K
-94.52%91.00K
14.75%319.00K
----
-92.70%160.00K
-37.62%1.66M
-66.06%278.00K
3.21%450.00K
231.47%2.19M
6390.24%2.66M
3176.00%819.00K
1306.45%436.00K
--661.00K
--41.00K
--25.00K
-24.39%31.00K
--41.00K
Net cash flow from business transactions
----
----
----
----
----
----
----
----
----
----
----
----
----
--0.00
----
----
----
--0.00
---14.32M
----
----
----
----
----
----
----
Net cash flow from investment products
-25.75%30.05M
0.11%32.32M
-41.30%28.32M
-13.85%29.81M
-34.29%40.47M
177.07%32.28M
141.11%48.24M
-52.76%34.61M
46.21%61.59M
-256.97%-41.89M
-641.38%-117.36M
151.65%73.25M
108.05%42.12M
-125.81%-11.73M
117.42%21.68M
-310.35%-141.82M
45.72%20.25M
605.71%45.46M
9.71%-124.46M
149.13%67.42M
--13.89M
---8.99M
---137.85M
---137.24M
----
----
Net cash flow from other investing activities
--0.00
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
Cash from non-current investing activities
Net cash flow from investing activities
-25.85%30.01M
0.51%32.45M
-41.30%28.32M
-11.92%30.38M
-34.24%40.48M
176.75%32.28M
141.08%48.24M
-52.71%34.49M
46.11%61.55M
-253.62%-42.06M
-686.73%-117.45M
151.32%72.93M
112.78%42.12M
-127.49%-11.89M
114.15%20.02M
-313.35%-142.10M
47.09%19.80M
548.36%43.27M
-2.58%-141.44M
148.52%66.60M
43512.90%13.46M
---9.65M
---137.89M
---137.26M
24.39%-31.00K
---41.00K
Financing cash flow
Cash flow from continuous financing activities
-694.18%-1.12M
---4.59M
25.00%115.00K
-100.00%0.00
2600.00%189.00K
--0.00
-70.23%92.00K
-100.00%9.00K
-98.12%7.00K
-100.00%0.00
-47.54%309.00K
12.97%236.62M
-70.35%373.00K
305.49%49.74M
-99.65%589.00K
66383.23%209.46M
--1.26M
2165.15%12.27M
6.84%166.57M
-100.16%-316.00K
-100.00%0.00
---594.00K
--155.90M
--191.66M
--13.47M
--0.00
Net cash flow from common stock issuance/repurchase
75.13%331.00K
---4.59M
25.00%115.00K
-100.00%0.00
-23.79%189.00K
--0.00
-70.23%92.00K
-100.00%9.00K
-33.51%248.00K
-100.00%0.00
--309.00K
--236.62M
-70.35%373.00K
270.84%49.74M
----
----
--1.26M
2358.08%13.41M
6.64%166.25M
-100.00%0.00
----
---594.00K
--155.90M
--172.48M
----
----
Net cash flow from preferred stock issuance/repurchase
----
----
----
----
----
----
----
----
----
----
----
----
----
--0.00
----
----
----
----
--0.00
--0.00
-100.00%0.00
--0.00
--0.00
--0.00
--14.23M
--0.00
Proceeds from stock option exercised by employees
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
---70.00K
--70.00K
----
----
----
----
----
----
Net cash flow from other financing activities
---1.45M
--0.00
--0.00
--0.00
100.00%0.00
--0.00
--0.00
--0.00
---241.00K
----
----
----
----
100.00%0.00
----
----
----
---1.15M
--386.00K
-151.19%-386.00K
100.00%0.00
----
----
--754.00K
---754.00K
--0.00
Net cash from non-recurrent financing activities
Net cash from financing activities
-694.18%-1.12M
---4.59M
25.00%115.00K
-100.00%0.00
2600.00%189.00K
--0.00
-70.23%92.00K
-100.00%9.00K
-98.12%7.00K
-100.00%0.00
-47.54%309.00K
12.97%236.62M
-70.35%373.00K
305.49%49.74M
-99.65%589.00K
66383.23%209.46M
--1.26M
2165.15%12.27M
6.84%166.57M
-100.16%-316.00K
-100.00%0.00
---594.00K
--155.90M
--191.66M
--13.47M
--0.00
Net cash flow
Beginning cash balance
5.73%38.62M
-5.12%41.70M
1.43%40.23M
10.57%44.56M
18.91%36.53M
-61.24%43.95M
-85.27%39.66M
3.57%40.30M
-32.78%30.72M
150.96%113.38M
365.96%269.19M
16.34%38.91M
-26.98%45.70M
2.51%45.18M
10.18%57.77M
3.66%33.44M
11.22%62.58M
-53.05%44.07M
-45.62%52.43M
-49.64%32.26M
-16.62%56.27M
--93.87M
--96.43M
--64.06M
168.30%67.49M
--25.15M
Current period cash flow changes
-150.64%-4.07M
58.53%-3.08M
-65.66%1.47M
-576.56%-4.33M
-16.18%8.03M
91.02%-7.42M
102.75%4.29M
-100.28%-640.00K
241.08%9.58M
-16057.34%-82.66M
-1137.35%-155.81M
846.56%230.28M
76.70%-6.79M
-97.20%518.00K
-50.57%-12.59M
20.59%24.33M
-21.37%-29.14M
149.24%18.51M
-227.32%-8.36M
-37.67%20.17M
-600.44%-24.01M
---37.60M
---2.56M
--32.37M
62.11%-3.43M
---9.05M
Ending cash balance
-22.44%34.56M
5.73%38.62M
-5.12%41.70M
1.43%40.23M
10.57%44.56M
18.91%36.53M
-61.24%43.95M
-85.27%39.66M
3.57%40.30M
-32.78%30.72M
150.96%113.38M
365.96%269.19M
16.34%38.91M
-26.98%45.70M
2.51%45.18M
10.18%57.77M
3.66%33.44M
11.22%62.58M
-53.05%44.07M
-45.62%52.43M
-49.64%32.26M
--56.27M
--93.87M
--96.43M
297.72%64.06M
--16.11M
Free cash flow
-1.08%-32.99M
22.07%-30.94M
38.78%-26.96M
1.73%-34.71M
37.26%-32.64M
2.62%-39.70M
-13.65%-44.05M
55.62%-35.32M
-5.54%-52.01M
-8.76%-40.77M
-11.18%-38.76M
-83.80%-79.59M
2.69%-49.28M
4.39%-37.49M
3.57%-34.86M
7.73%-43.30M
-33.61%-50.65M
-39.95%-39.21M
-75.45%-36.15M
-112.77%-46.93M
-124.26%-37.91M
---28.02M
---20.61M
---22.06M
-86.82%-16.90M
---9.05M
Currency unit
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
Audit opinions
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----

FAQs

What is operating cash flow?

Operating cash flow is the cash generated or used by a company's core business operations. It adjusts net income for non-cash items and working capital changes, such as depreciation, receivables, inventory, and payables. Strong operating cash flow can indicate that the business is converting sales and earnings into real cash.

How Much Operating Cash Flow Did Zentalis Pharmaceuticals Inc Generate?

Zentalis Pharmaceuticals Inc generated -125.25M in operating cash flow in fiscal 2025, reflecting cash generated from its core business operations.

How Did Zentalis Pharmaceuticals Inc's Operating Cash Flow Change Year Over Year?

Zentalis Pharmaceuticals Inc's operating cash flow increased by 26.70% year over year.

What is investing cash flow?

Investing cash flow shows cash used for or generated from investment-related activities, such as capital expenditures, purchases or sales of investments, acquisitions, and asset disposals. Negative investing cash flow is not always bad, because it can reflect spending on future growth, but investors should check whether those investments support long-term returns.

What is financing cash flow?

Financing cash flow shows how a company raises capital or returns capital to investors and creditors. It can include debt issuance, debt repayment, share issuance, share repurchases, dividend payments, and lease financing. Positive financing cash flow may show new capital raised, while negative financing cash flow may reflect debt repayment, dividends, or buybacks.

How Has Zentalis Pharmaceuticals Inc's Financing Cash Flow Changed?

Zentalis Pharmaceuticals Inc used -4.28M in financing activities in the latest quarter.

What is free cash flow and why does it matter for ZNTL?

Free cash flow is the cash a company has left after funding the capital spending needed to maintain or grow the business. It is often used to assess financial flexibility, debt repayment capacity, dividend sustainability, buyback potential, and valuation quality. Investors should compare free cash flow with net income, revenue growth, and capital expenditures.

What was Zentalis Pharmaceuticals Inc’s free cash flow in the latest quarter?

Free cash flow was -125.25M reflecting a 26.79% change from the previous year.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.